Chemoprophylaxis with erythromycin stearate of amoxycillin in patients with chronic bronchitis - effects on cellular and humoral immune functions

Twenty-six patients aged between 27 and 71 years with chronic bronchitis were divided into a control group of 6 and two groups of 10 patients each who received either erythromycin stearate or amoxycillin 1500 mg/d for 2 weeks and 1000 mg/d for 12 weeks thereafter.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	South African Medical Journal/Suid-Afrikaanse Mediese Tydskrift 1984-01, Vol.66 (25), p.955-958
1. Verfasser:	Ras, G.J., Anderson, R., Eftychis, H.A., Koch, U., Theron, A., van Wyk, H.A. & Olivier, L.R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Amoxicillin - pharmacology Amoxicillin - therapeutic use Amoxycillin Biological and medical sciences Bronchitis - drug therapy Bronchitis - immunology Cellular immune function Chemoprophylaxis Chemotaxis, Leukocyte - drug effects Chronic bronchitis Chronic Disease Erythromycin - analogs & derivatives Erythromycin - pharmacology Erythromycin - therapeutic use Erythromycin stearate Female Humans Humoral immune function Hypersensitivity, Delayed - immunology Immunoglobulins - analysis Immunology Leukocytes - immunology Lung function Male Medical sciences Microbiology Middle Aged Neutrophils - immunology Pharmacology Pneumology Pulmonology Respiratory Function Tests Respiratory system : syndromes and miscellaneous diseases Side-effects Tropical medicine
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Twenty-six patients aged between 27 and 71 years with chronic bronchitis were divided into a control group of 6 and two groups of 10 patients each who received either erythromycin stearate or amoxycillin 1500 mg/d for 2 weeks and 1000 mg/d for 12 weeks thereafter.
ISSN:	0256-9574 0038-2469 2078-5135